Switching from low‐dose thiazide diuretics to sodium–glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension

AIMS/INTRODUCTION: Sodium–glucose cotransporter 2 (SGLT2) inhibitors function to increase urinary glucose excretion and improve glycemic control in individuals with type 2 diabetes mellitus. SGLT2 inhibitors, as well as diuretics, increase urinary volume, which leads to the reduction of blood pressu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Tomohiko, Sanada, Junpei, Shimoda, Masashi, Hirukawa, Hidenori, Fushimi, Yoshiro, Nishioka, Momoyo, Kinoshita, Tomoe, Okauchi, Seizo, Obata, Atsushi, Kohara, Kenji, Tatsumi, Fuminori, Kamei, Shinji, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031496/
https://www.ncbi.nlm.nih.gov/pubmed/29110406
http://dx.doi.org/10.1111/jdi.12774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031496/
https://www.ncbi.nlm.nih.gov/pubmed/29110406
http://dx.doi.org/10.1111/jdi.12774

Ejemplares similares